SMTL ID : 9h66.2 (2 other biounits)

Steroidal Selective Modulators of FXR with Therapeutic Potential

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.60 Å

Oligo State

hetero-2-3-mer

Ligands

2 x R3U: (4~{R})-4-[(3~{R},4~{R},5~{S},6~{R},7~{R},8~{S},9~{S},10~{R},13~{R},14~{R},17~{R})-6-ethyl-4-fluoranyl-10,13-dimethyl-3,7-bis(oxidanyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1~{H}-cyclopenta[a]phenanthren-17-yl]-~{N}-[4-(trifluoromethyloxy)phenyl]sulfonyl-pentanamide(Non-covalent)

R3U.1: 23 residues within 4Å: Chain A: Y.21, R.25, M.26, M.51, N.54, H.55, V.58, L.59, F.62, M.89, F.90, R.92, S.93, I.96, F.97, I.113, I.118, Y.122, I.123, M.126, Y.130, T.147, H.208 19 PLIP interactions: 19 interactions with chain A Hydrophobic interactions: A:H.55, A:V.58, A:I.96, A:F.97, A:I.113, A:I.113, A:I.118, A:I.123 Hydrogen bonds: A:Y.21, A:M.26, A:R.92, A:S.93, A:S.93, A:Y.122, A:Y.130, A:H.208 Water bridges: A:K.100 Halogen bonds: A:Y.21, A:V.58 R3U.2: 25 residues within 4Å: Chain B: Y.21, R.25, M.26, L.48, M.51, H.55, V.58, L.59, F.62, M.89, F.90, R.92, S.93, I.96, I.113, I.118, Y.122, I.123, M.126, F.127, Y.130, H.208, M.211, W.215, W.230 17 PLIP interactions: 17 interactions with chain B Hydrophobic interactions: B:L.48, B:M.51, B:H.55, B:V.58, B:I.96, B:I.113, B:I.113, B:I.118, B:I.123, B:F.127, B:W.215, B:W.230 Hydrogen bonds: B:M.26, B:R.92, B:S.93, B:S.93, B:H.208

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kydd-Sinclair, D. et al., Structural Basis of Novel Bile Acid-Based Modulators of FXR. J.Mol.Biol. (2025)

Release Date

2025-09-10

Peptides

Bile acid receptor: AB
Nuclear receptor coactivator 2: CDE

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

B
D

C
H

D
I

E
J

Bile acid receptor

Nuclear receptor coactivator 2

Related Entries With Identical Sequence